WallStreetZenWallStreetZen

NASDAQ: AQST
Aquestive Therapeutics Inc Earnings & Revenue

AQST past revenue growth

How has AQST's revenue growth performed historically?
Company
6.09%
Industry
9.78%
Market
17.86%
AQST's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
AQST's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
AQST's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

AQST earnings and revenue history

Current Revenue
$50.6M
Current Earnings
-$7.9M
Current Profit Margin
-15.6%

AQST Return on Equity

Insufficient data to display

Be the first to know when AQST announces earnings.

AQST Return on Assets

Current Company
-13.4%
Current Industry
3.4%
AQST is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

AQST Return on Capital Employed

Current Company
-0.42%
Current Industry
5.1%
AQST has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

AQST vs Pharmaceutical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
AQST$50.58M$1.18M-$7.87M-5.59%N/A
PROC$414.10M$75.58M$52.20M-61.31%-38.62%
KMDA$142.52M$22.44M$8.28M+4.48%-20.93%
ORGO$433.14M$36.03M$4.95M+17.49%-90.86%
ACB$199.23M-$66.17M-$106.90M+17.87%N/A

AQST earnings dates

Next earnings date
Apr 30, 2024

Aquestive Therapeutics Earnings & Revenue FAQ

What were AQST's earnings last quarter?

On Invalid Date, Aquestive Therapeutics (NASDAQ: AQST) reported Q4 2023 earnings per share (EPS) of -$0.13, up 40.91% year over year. Total Aquestive Therapeutics earnings for the quarter were -$8.11 million. In the same quarter last year, Aquestive Therapeutics's earnings per share (EPS) was -$0.22.

If you're new to stock investing, here's how to buy Aquestive Therapeutics stock.

What was AQST's earnings growth in the past year?

As of Q1 2024, Aquestive Therapeutics's earnings has grown year over year. Aquestive Therapeutics's earnings in the past year totalled -$7.87 million.

What is AQST's earnings date?

Aquestive Therapeutics's earnings date is Invalid Date. Add AQST to your watchlist to be reminded of AQST's next earnings announcement.

What was AQST's revenue last quarter?

On Invalid Date, Aquestive Therapeutics (NASDAQ: AQST) reported Q4 2023 revenue of $13.21 million up 23.63% year over year. In the same quarter last year, Aquestive Therapeutics's revenue was $10.68 million.

What was AQST's revenue growth in the past year?

As of Q1 2024, Aquestive Therapeutics's revenue has grown 6.09% year over year. This is 3.69 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 9.78%. Aquestive Therapeutics's revenue in the past year totalled $50.58 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.